Sold 1,004 shares
of Common Stock
at $3.065 per share
(Direct)
Date: 2025-08-18 |
Code: S
| equity_swap_involved: 0 | shares_owned_after: 136,050.00 | transaction_form_type: 4 | Footnotes: F1, F2
Sold 588 shares
of Common Stock
at $2.996 per share
(Direct)
Date: 2025-08-19 |
Code: S
| equity_swap_involved: 0 | shares_owned_after: 135,462.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
🔍 Wilson Martin (Executive)
Company: ROCKET PHARMACEUTICALS, INC. (RCKT)
Report Date: 2025-08-18
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 136,050.00 | transaction_form_type: 4 | Footnotes: F1, F2
Date: 2025-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 135,462.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes: